Cozid 250 mg/vial (IM/IV Injection)
250 mg vial: ৳ 85.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Ceftazidime pentahydrate |
| Company | Beacon pharmaceuticals plc |
| Also available as |
Indications
- Lower Respiratory Tract Infections
- Skin and Skin Structure Infections
- Urinary Tract Infections
- Bacterial Septicemia
- Bone and Joint Infections
- Gynecologic Infections
- Intraabdominal Infections
- Central Nervous System Infections
Pharmacology
- Bactericidal action
- Inhibition of enzymes responsible for cell-wall synthesis
- Susceptibility to gram-negative organisms
- Activity against gram-positive organisms
- Stability to beta-lactamases
Dosage
- Usual adult dosage of 1 gram every 8 to 12 hours
- Dosage determined by susceptibility of causative organisms
- Adult dosage range of 1 to 6 gm per day
- Different dosages for urinary tract infections and severe infections
- Reduced clearance in acutely ill elderly patients
Administration
- Intravenous or deep IM injection
- Reconstitution with Sterile Water for Injection
- Avoidance of intra-arterial administration
Contraindications
- Hypersensitivity to Ceftazidime or cephalosporin antibiotics
Side Effects
- Local reactions following IV injection
- Allergic and gastrointestinal reactions
- Hypersensitivity reactions
- Gastrointestinal symptoms
- Central nervous system reactions
Pregnancy & Lactation
- Use in pregnancy only if clearly needed
- Excretion in human milk at low concentrations
- Consideration of discontinue nursing or drug
Precautions & Warnings
- Reduction in total daily dosage for patients with renal insufficiency
- Caution in individuals with history of gastrointestinal disease
Use in Special Populations
- Dosage reduction for impaired renal function
- Usage in peritoneal dialysis and CAPD
- No dosage adjustment for impaired hepatic function
Overdose Effects
- Seizure activity
- Encephalopathy
- Neuromuscular excitability
- Coma
- Supportive treatment for acute overdosage
Therapeutic Class
- Third generation Cephalosporins
Reconstitution
- Amount of WFI for various dosages and routes of administration
Storage Conditions
- Storage below 25°C
- Protection from light and moisture
- Stability of reconstituted solutions for up to 24 hours at 2°C-8°C